Aptevo Therapeutics Inc

APVO

Add to Watchlist

4.470USD

+0.020+0.45%

Close 07/02, 13:00（ET）Quotes delayed by 15 min

5.38MMarket Cap

0.00P/E TTM

Aptevo Therapeutics Inc

4.470

+0.020+0.45%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Aptevo Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-02

Previous score

6.90

Change

2.07

The current valuation score of Aptevo Therapeutics Inc is 8.97, ranking 68 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.00, which is 53696.67% below the recent high of 1.61 and 18503.33% above the recent low of -0.55.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.